Thrombosis risk stratification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
*'''Medical''' | *'''Medical''' | ||
**Surgery | **Surgery | ||
**[[Congestive heart failure and thrombosis|Heart failure]] | |||
**[[Trauma]] | **[[Trauma]] | ||
**[[Oral contraceptive]] use | **[[Oral contraceptive]] use |
Revision as of 18:44, 28 September 2011
Thrombosis Microchapters |
Site of Thrombosis |
---|
Differentiating Thrombosis from other Diseases |
Diagnosis |
Treatment |
Thrombosis risk stratification On the Web |
Risk calculators and risk factors for Thrombosis risk stratification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Overview
Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.
Risk factors
- Medical
- Familial
- Antithrombin III deficiency
- Protein C deficiency/Protein S deficiency
- APC resistance (Factor V Leiden)
- Dysfibrogenemia
- Hypoplasminogenemia
- Familial homocysteinemia
cs:Trombóza de:Thrombose eo:Trombozo it:Trombosi he:תרומבוס ms:Trombotik nl:Trombose fi:Verihiutale